APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Modafinil Oral Drugs

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Modafinil Oral Drugs Market Outlook and Growth Opportunities 2026

Report ID 174013910427 December 2025194 pages

Choose your research edition.

Industry ResearchModafinil Oral Drugs Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Modafinil Oral Drugs Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Modafinil Oral Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Modafinil Oral Drugs Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Modafinil Oral Drugs Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Modafinil Oral Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Modafinil Oral Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Modafinil Oral Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Modafinil Oral Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Modafinil Oral Drugs market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Modafinil Oral Drugs market include Xiangbei Welman Pharmaceutical, Zydus, Watson Labs, Sun Pharmaceutical, Orbion Pharmaceuticals, Cephalon, Aurobindo Pharma, Apotex and Alembic Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Modafinil Oral Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Modafinil Oral Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Modafinil Oral Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Modafinil Oral Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Modafinil Oral Drugs Segment by Company

Xiangbei Welman Pharmaceutical

Zydus

Watson Labs

Sun Pharmaceutical

Orbion Pharmaceuticals

Cephalon

Aurobindo Pharma

Apotex

Alembic Pharma

Modafinil Oral Drugs Segment by Type

Tablets

Capsules

Modafinil Oral Drugs Segment by Application

Obstructive Sleep Apnea

Shift Work Sleep Disorder

Narcolepsy

Other

Modafinil Oral Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Modafinil Oral Drugs status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Modafinil Oral Drugs market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Modafinil Oral Drugs significant trends, drivers, influence factors in global and regions.

6. To analyze Modafinil Oral Drugs competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Modafinil Oral Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Modafinil Oral Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Modafinil Oral Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Modafinil Oral Drugs market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Modafinil Oral Drugs industry.

Chapter 3: Detailed analysis of Modafinil Oral Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Modafinil Oral Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Modafinil Oral Drugs in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Modafinil Oral Drugs Industry Trends Table 2. Modafinil Oral Drugs Industry Drivers Table 3. Modafinil Oral Drugs Industry Opportunities and Challenges Table 4. Modafinil Oral Drugs Industry Restraints Table 5. Global Modafinil Oral Drugs Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Modafinil Oral Drugs Revenue Share by Company (2021-2026) Table 7. Global Modafinil Oral Drugs Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Modafinil Oral Drugs Sales Volume Share by Company (2021-2026) Table 9. Global Modafinil Oral Drugs Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Modafinil Oral Drugs Company Ranking, (2024-2026) & (USD Million) Table 11. Global Modafinil Oral Drugs Key Company Manufacturing Base & Headquarters Table 12. Global Modafinil Oral Drugs Company, Product Type & Application Table 13. Global Modafinil Oral Drugs Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Modafinil Oral Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Tablets Table 18. Significant Companies of Capsules Table 19. Global Modafinil Oral Drugs Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Modafinil Oral Drugs Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Modafinil Oral Drugs Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Modafinil Oral Drugs Sales Volume Share by Type (2021-2026) Table 23. Global Modafinil Oral Drugs Sales Volume Share by Type (2027-2032) Table 24. Global Modafinil Oral Drugs Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Modafinil Oral Drugs Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Modafinil Oral Drugs Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Modafinil Oral Drugs Sales Value Share by Type (2021-2026) Table 28. Global Modafinil Oral Drugs Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Obstructive Sleep Apnea Table 30. Significant Companies of Shift Work Sleep Disorder Table 31. Significant Companies of Narcolepsy Table 32. Significant Companies of Other Table 33. Global Modafinil Oral Drugs Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Modafinil Oral Drugs Sales Volume by Application (2021-2026) & (K Units) Table 35. Global Modafinil Oral Drugs Sales Volume by Application (2027-2032) & (K Units) Table 36. Global Modafinil Oral Drugs Sales Volume Share by Application (2021-2026) Table 37. Global Modafinil Oral Drugs Sales Volume Share by Application (2027-2032) Table 38. Global Modafinil Oral Drugs Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Modafinil Oral Drugs Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Modafinil Oral Drugs Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Modafinil Oral Drugs Sales Value Share by Application (2021-2026) Table 42. Global Modafinil Oral Drugs Sales Value Share by Application (2027-2032) Table 43. Global Modafinil Oral Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Modafinil Oral Drugs Sales by Region (2021-2026) & (K Units) Table 45. Global Modafinil Oral Drugs Sales Market Share by Region (2021-2026) Table 46. Global Modafinil Oral Drugs Sales by Region (2027-2032) & (K Units) Table 47. Global Modafinil Oral Drugs Sales Market Share by Region (2027-2032) Table 48. Global Modafinil Oral Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Modafinil Oral Drugs Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Modafinil Oral Drugs Sales Value Share by Region (2021-2026) Table 51. Global Modafinil Oral Drugs Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Modafinil Oral Drugs Sales Value Share by Region (2027-2032) Table 53. Global Modafinil Oral Drugs Market Average Price (US$/Unit) by Region (2021-2026) Table 54. Global Modafinil Oral Drugs Market Average Price (US$/Unit) by Region (2027-2032) Table 55. Global Modafinil Oral Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Global Modafinil Oral Drugs Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Modafinil Oral Drugs Sales by Country (2021-2026) & (K Units) Table 58. Global Modafinil Oral Drugs Sales Market Share by Country (2021-2026) Table 59. Global Modafinil Oral Drugs Sales by Country (2027-2032) & (K Units) Table 60. Global Modafinil Oral Drugs Sales Market Share by Country (2027-2032) Table 61. Global Modafinil Oral Drugs Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Modafinil Oral Drugs Sales Value Market Share by Country (2021-2026) Table 63. Global Modafinil Oral Drugs Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Modafinil Oral Drugs Sales Value Market Share by Country (2027-2032) Table 65. Xiangbei Welman Pharmaceutical Company Information Table 66. Xiangbei Welman Pharmaceutical Business Overview Table 67. Xiangbei Welman Pharmaceutical Modafinil Oral Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Xiangbei Welman Pharmaceutical Modafinil Oral Drugs Product Portfolio Table 69. Xiangbei Welman Pharmaceutical Recent Development Table 70. Zydus Company Information Table 71. Zydus Business Overview Table 72. Zydus Modafinil Oral Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Zydus Modafinil Oral Drugs Product Portfolio Table 74. Zydus Recent Development Table 75. Watson Labs Company Information Table 76. Watson Labs Business Overview Table 77. Watson Labs Modafinil Oral Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Watson Labs Modafinil Oral Drugs Product Portfolio Table 79. Watson Labs Recent Development Table 80. Sun Pharmaceutical Company Information Table 81. Sun Pharmaceutical Business Overview Table 82. Sun Pharmaceutical Modafinil Oral Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Sun Pharmaceutical Modafinil Oral Drugs Product Portfolio Table 84. Sun Pharmaceutical Recent Development Table 85. Orbion Pharmaceuticals Company Information Table 86. Orbion Pharmaceuticals Business Overview Table 87. Orbion Pharmaceuticals Modafinil Oral Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Orbion Pharmaceuticals Modafinil Oral Drugs Product Portfolio Table 89. Orbion Pharmaceuticals Recent Development Table 90. Cephalon Company Information Table 91. Cephalon Business Overview Table 92. Cephalon Modafinil Oral Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Cephalon Modafinil Oral Drugs Product Portfolio Table 94. Cephalon Recent Development Table 95. Aurobindo Pharma Company Information Table 96. Aurobindo Pharma Business Overview Table 97. Aurobindo Pharma Modafinil Oral Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Aurobindo Pharma Modafinil Oral Drugs Product Portfolio Table 99. Aurobindo Pharma Recent Development Table 100. Apotex Company Information Table 101. Apotex Business Overview Table 102. Apotex Modafinil Oral Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Apotex Modafinil Oral Drugs Product Portfolio Table 104. Apotex Recent Development Table 105. Alembic Pharma Company Information Table 106. Alembic Pharma Business Overview Table 107. Alembic Pharma Modafinil Oral Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Alembic Pharma Modafinil Oral Drugs Product Portfolio Table 109. Alembic Pharma Recent Development Table 110. Key Raw Materials Table 111. Raw Materials Key Suppliers Table 112. Modafinil Oral Drugs Distributors List Table 113. Modafinil Oral Drugs Customers List Table 114. Research Programs/Design for This Report Table 115. Authors List of This Report Table 116. Secondary Sources Table 117. Primary Sources List of Figures Figure 1. Modafinil Oral Drugs Product Image Figure 2. Global Modafinil Oral Drugs Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Modafinil Oral Drugs Sales Value (2021-2032) & (US$ Million) Figure 4. Global Modafinil Oral Drugs Sales (2021-2032) & (K Units) Figure 5. Global Modafinil Oral Drugs Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Modafinil Oral Drugs Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Tablets Image Figure 10. Capsules Image Figure 11. Global Modafinil Oral Drugs Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Modafinil Oral Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Modafinil Oral Drugs Sales Volume Share by Type (2021-2032) Figure 14. Global Modafinil Oral Drugs Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Modafinil Oral Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Modafinil Oral Drugs Sales Value Share by Type (2021-2032) Figure 17. Obstructive Sleep Apnea Image Figure 18. Shift Work Sleep Disorder Image Figure 19. Narcolepsy Image Figure 20. Other Image Figure 21. Global Modafinil Oral Drugs Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Modafinil Oral Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Modafinil Oral Drugs Sales Volume Share by Application (2021-2032) Figure 24. Global Modafinil Oral Drugs Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Modafinil Oral Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Modafinil Oral Drugs Sales Value Share by Application (2021-2032) Figure 27. Global Modafinil Oral Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 28. Global Modafinil Oral Drugs Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Modafinil Oral Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Modafinil Oral Drugs Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Modafinil Oral Drugs Sales Value (2021-2032) & (US$ Million) Figure 32. North America Modafinil Oral Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Modafinil Oral Drugs Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Modafinil Oral Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Modafinil Oral Drugs Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Modafinil Oral Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Modafinil Oral Drugs Sales Value (2021-2032) & (US$ Million) Figure 38. South America Modafinil Oral Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Modafinil Oral Drugs Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Modafinil Oral Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Modafinil Oral Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Modafinil Oral Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Modafinil Oral Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Modafinil Oral Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Modafinil Oral Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Modafinil Oral Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Modafinil Oral Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Modafinil Oral Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Modafinil Oral Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Modafinil Oral Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Modafinil Oral Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Modafinil Oral Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Modafinil Oral Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Modafinil Oral Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Modafinil Oral Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Modafinil Oral Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Modafinil Oral Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Modafinil Oral Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Modafinil Oral Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Modafinil Oral Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Modafinil Oral Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Modafinil Oral Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Modafinil Oral Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Modafinil Oral Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Modafinil Oral Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Modafinil Oral Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Modafinil Oral Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Modafinil Oral Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Modafinil Oral Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Modafinil Oral Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Modafinil Oral Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Modafinil Oral Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Modafinil Oral Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Modafinil Oral Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Modafinil Oral Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Modafinil Oral Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Modafinil Oral Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Modafinil Oral Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Modafinil Oral Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Modafinil Oral Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Modafinil Oral Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Modafinil Oral Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Modafinil Oral Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Modafinil Oral Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Modafinil Oral Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Modafinil Oral Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Modafinil Oral Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Modafinil Oral Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Modafinil Oral Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Modafinil Oral Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Modafinil Oral Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Modafinil Oral Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Modafinil Oral Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Modafinil Oral Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Modafinil Oral Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Modafinil Oral Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Modafinil Oral Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Modafinil Oral Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Modafinil Oral Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Modafinil Oral Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Modafinil Oral Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Modafinil Oral Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Modafinil Oral Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Modafinil Oral Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Modafinil Oral Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Modafinil Oral Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Modafinil Oral Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Modafinil Oral Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Modafinil Oral Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Modafinil Oral Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Modafinil Oral Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Modafinil Oral Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Modafinil Oral Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Modafinil Oral Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Modafinil Oral Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Modafinil Oral Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Modafinil Oral Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Modafinil Oral Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Modafinil Oral Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Modafinil Oral Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Modafinil Oral Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Modafinil Oral Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Modafinil Oral Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Modafinil Oral Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Modafinil Oral Drugs Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Modafinil Oral Drugs Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Tablets
  • Capsules
Applications
  • Obstructive Sleep Apnea
  • Shift Work Sleep Disorder
  • Narcolepsy
  • Other
Companies covered
  • Xiangbei Welman Pharmaceutical
  • Zydus
  • Watson Labs
  • Sun Pharmaceutical
  • Orbion Pharmaceuticals
  • Cephalon
  • Aurobindo Pharma
  • Apotex
  • Alembic Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Modafinil Oral Drugs Sales Value (2021-2032)
  4. 1.2.2 Global Modafinil Oral Drugs Sales Volume (2021-2032)
  5. 1.2.3 Global Modafinil Oral Drugs Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Modafinil Oral Drugs Market Dynamics
  1. 2.1 Modafinil Oral Drugs Industry Trends
  2. 2.2 Modafinil Oral Drugs Industry Drivers
  3. 2.3 Modafinil Oral Drugs Industry Opportunities and Challenges
  4. 2.4 Modafinil Oral Drugs Industry Restraints
3 Modafinil Oral Drugs Market by Company
  1. 3.1 Global Modafinil Oral Drugs Company Revenue Ranking in 2025
  2. 3.2 Global Modafinil Oral Drugs Revenue by Company (2021-2026)
  3. 3.3 Global Modafinil Oral Drugs Sales Volume by Company (2021-2026)
  4. 3.4 Global Modafinil Oral Drugs Average Price by Company (2021-2026)
  5. 3.5 Global Modafinil Oral Drugs Company Ranking (2024-2026)
  6. 3.6 Global Modafinil Oral Drugs Company Manufacturing Base and Headquarters
  7. 3.7 Global Modafinil Oral Drugs Company Product Type and Application
  8. 3.8 Global Modafinil Oral Drugs Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Modafinil Oral Drugs Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Modafinil Oral Drugs Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Modafinil Oral Drugs Market by Type
  1. 4.1 Modafinil Oral Drugs Type Introduction
  2. 4.1.1 Tablets
  3. 4.1.2 Capsules
  4. 4.2 Global Modafinil Oral Drugs Sales Volume by Type
  5. 4.2.1 Global Modafinil Oral Drugs Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Modafinil Oral Drugs Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Modafinil Oral Drugs Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Modafinil Oral Drugs Sales Value by Type
  9. 4.3.1 Global Modafinil Oral Drugs Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Modafinil Oral Drugs Sales Value by Type (2021-2032)
  11. 4.3.3 Global Modafinil Oral Drugs Sales Value Share by Type (2021-2032)
5 Modafinil Oral Drugs Market by Application
  1. 5.1 Modafinil Oral Drugs Application Introduction
  2. 5.1.1 Obstructive Sleep Apnea
  3. 5.1.2 Shift Work Sleep Disorder
  4. 5.1.3 Narcolepsy
  5. 5.1.4 Other
  6. 5.2 Global Modafinil Oral Drugs Sales Volume by Application
  7. 5.2.1 Global Modafinil Oral Drugs Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Modafinil Oral Drugs Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Modafinil Oral Drugs Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Modafinil Oral Drugs Sales Value by Application
  11. 5.3.1 Global Modafinil Oral Drugs Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Modafinil Oral Drugs Sales Value by Application (2021-2032)
  13. 5.3.3 Global Modafinil Oral Drugs Sales Value Share by Application (2021-2032)
6 Modafinil Oral Drugs Regional Sales and Value Analysis
  1. 6.1 Global Modafinil Oral Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Modafinil Oral Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Modafinil Oral Drugs Sales by Region: 2021-2026
  4. 6.2.2 Global Modafinil Oral Drugs Sales by Region (2027-2032)
  5. 6.3 Global Modafinil Oral Drugs Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Modafinil Oral Drugs Sales Value by Region (2021-2032)
  7. 6.4.1 Global Modafinil Oral Drugs Sales Value by Region: 2021-2026
  8. 6.4.2 Global Modafinil Oral Drugs Sales Value by Region (2027-2032)
  9. 6.5 Global Modafinil Oral Drugs Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Modafinil Oral Drugs Sales Value (2021-2032)
  12. 6.6.2 North America Modafinil Oral Drugs Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Modafinil Oral Drugs Sales Value (2021-2032)
  15. 6.7.2 Europe Modafinil Oral Drugs Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Modafinil Oral Drugs Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Modafinil Oral Drugs Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Modafinil Oral Drugs Sales Value (2021-2032)
  21. 6.9.2 South America Modafinil Oral Drugs Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Modafinil Oral Drugs Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Modafinil Oral Drugs Sales Value Share by Country, 2025 VS 2032
7 Modafinil Oral Drugs Country-level Sales and Value Analysis
  1. 7.1 Global Modafinil Oral Drugs Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Modafinil Oral Drugs Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Modafinil Oral Drugs Sales by Country (2021-2032)
  4. 7.3.1 Global Modafinil Oral Drugs Sales by Country (2021-2026)
  5. 7.3.2 Global Modafinil Oral Drugs Sales by Country (2027-2032)
  6. 7.4 Global Modafinil Oral Drugs Sales Value by Country (2021-2032)
  7. 7.4.1 Global Modafinil Oral Drugs Sales Value by Country (2021-2026)
  8. 7.4.2 Global Modafinil Oral Drugs Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Modafinil Oral Drugs Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Modafinil Oral Drugs Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Modafinil Oral Drugs Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Modafinil Oral Drugs Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Modafinil Oral Drugs Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Modafinil Oral Drugs Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Modafinil Oral Drugs Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Modafinil Oral Drugs Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Modafinil Oral Drugs Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Modafinil Oral Drugs Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Modafinil Oral Drugs Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Modafinil Oral Drugs Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Modafinil Oral Drugs Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Modafinil Oral Drugs Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Modafinil Oral Drugs Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Modafinil Oral Drugs Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Modafinil Oral Drugs Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Modafinil Oral Drugs Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Modafinil Oral Drugs Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Modafinil Oral Drugs Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Modafinil Oral Drugs Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Modafinil Oral Drugs Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Modafinil Oral Drugs Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Modafinil Oral Drugs Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Modafinil Oral Drugs Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Modafinil Oral Drugs Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Modafinil Oral Drugs Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Modafinil Oral Drugs Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Modafinil Oral Drugs Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Modafinil Oral Drugs Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Modafinil Oral Drugs Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Modafinil Oral Drugs Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Modafinil Oral Drugs Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Modafinil Oral Drugs Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Modafinil Oral Drugs Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Modafinil Oral Drugs Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Modafinil Oral Drugs Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Modafinil Oral Drugs Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Modafinil Oral Drugs Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Modafinil Oral Drugs Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Modafinil Oral Drugs Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Modafinil Oral Drugs Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Modafinil Oral Drugs Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Modafinil Oral Drugs Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Modafinil Oral Drugs Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Modafinil Oral Drugs Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Modafinil Oral Drugs Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Modafinil Oral Drugs Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Modafinil Oral Drugs Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Modafinil Oral Drugs Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Modafinil Oral Drugs Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Modafinil Oral Drugs Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Modafinil Oral Drugs Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Modafinil Oral Drugs Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Modafinil Oral Drugs Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Modafinil Oral Drugs Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Modafinil Oral Drugs Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Modafinil Oral Drugs Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Modafinil Oral Drugs Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Modafinil Oral Drugs Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Modafinil Oral Drugs Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Modafinil Oral Drugs Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Modafinil Oral Drugs Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Modafinil Oral Drugs Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Modafinil Oral Drugs Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Modafinil Oral Drugs Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Modafinil Oral Drugs Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Modafinil Oral Drugs Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Modafinil Oral Drugs Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Modafinil Oral Drugs Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Modafinil Oral Drugs Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Modafinil Oral Drugs Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Modafinil Oral Drugs Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Modafinil Oral Drugs Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Modafinil Oral Drugs Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Modafinil Oral Drugs Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Modafinil Oral Drugs Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Modafinil Oral Drugs Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Modafinil Oral Drugs Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Modafinil Oral Drugs Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Modafinil Oral Drugs Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Modafinil Oral Drugs Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Modafinil Oral Drugs Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Modafinil Oral Drugs Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Xiangbei Welman Pharmaceutical
  2. 8.1.1 Xiangbei Welman Pharmaceutical Company Information
  3. 8.1.2 Xiangbei Welman Pharmaceutical Business Overview
  4. 8.1.3 Xiangbei Welman Pharmaceutical Modafinil Oral Drugs Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Xiangbei Welman Pharmaceutical Modafinil Oral Drugs Product Portfolio
  6. 8.1.5 Xiangbei Welman Pharmaceutical Recent Developments
  7. 8.2 Zydus
  8. 8.2.1 Zydus Company Information
  9. 8.2.2 Zydus Business Overview
  10. 8.2.3 Zydus Modafinil Oral Drugs Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Zydus Modafinil Oral Drugs Product Portfolio
  12. 8.2.5 Zydus Recent Developments
  13. 8.3 Watson Labs
  14. 8.3.1 Watson Labs Company Information
  15. 8.3.2 Watson Labs Business Overview
  16. 8.3.3 Watson Labs Modafinil Oral Drugs Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Watson Labs Modafinil Oral Drugs Product Portfolio
  18. 8.3.5 Watson Labs Recent Developments
  19. 8.4 Sun Pharmaceutical
  20. 8.4.1 Sun Pharmaceutical Company Information
  21. 8.4.2 Sun Pharmaceutical Business Overview
  22. 8.4.3 Sun Pharmaceutical Modafinil Oral Drugs Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Sun Pharmaceutical Modafinil Oral Drugs Product Portfolio
  24. 8.4.5 Sun Pharmaceutical Recent Developments
  25. 8.5 Orbion Pharmaceuticals
  26. 8.5.1 Orbion Pharmaceuticals Company Information
  27. 8.5.2 Orbion Pharmaceuticals Business Overview
  28. 8.5.3 Orbion Pharmaceuticals Modafinil Oral Drugs Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Orbion Pharmaceuticals Modafinil Oral Drugs Product Portfolio
  30. 8.5.5 Orbion Pharmaceuticals Recent Developments
  31. 8.6 Cephalon
  32. 8.6.1 Cephalon Company Information
  33. 8.6.2 Cephalon Business Overview
  34. 8.6.3 Cephalon Modafinil Oral Drugs Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Cephalon Modafinil Oral Drugs Product Portfolio
  36. 8.6.5 Cephalon Recent Developments
  37. 8.7 Aurobindo Pharma
  38. 8.7.1 Aurobindo Pharma Company Information
  39. 8.7.2 Aurobindo Pharma Business Overview
  40. 8.7.3 Aurobindo Pharma Modafinil Oral Drugs Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Aurobindo Pharma Modafinil Oral Drugs Product Portfolio
  42. 8.7.5 Aurobindo Pharma Recent Developments
  43. 8.8 Apotex
  44. 8.8.1 Apotex Company Information
  45. 8.8.2 Apotex Business Overview
  46. 8.8.3 Apotex Modafinil Oral Drugs Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Apotex Modafinil Oral Drugs Product Portfolio
  48. 8.8.5 Apotex Recent Developments
  49. 8.9 Alembic Pharma
  50. 8.9.1 Alembic Pharma Company Information
  51. 8.9.2 Alembic Pharma Business Overview
  52. 8.9.3 Alembic Pharma Modafinil Oral Drugs Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Alembic Pharma Modafinil Oral Drugs Product Portfolio
  54. 8.9.5 Alembic Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Modafinil Oral Drugs Value Chain Analysis
  2. 9.1.1 Modafinil Oral Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Modafinil Oral Drugs Sales Mode & Process
  6. 9.2 Modafinil Oral Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Modafinil Oral Drugs Distributors
  9. 9.2.3 Modafinil Oral Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst